| Title |
A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
|
|---|---|
| Published in |
Psychopharmacology, October 2013
|
| DOI | 10.1007/s00213-013-3316-1 |
| Pubmed ID | |
| Authors |
Liisa Hantsoo, Deborah Ward-O’Brien, Kathryn A. Czarkowski, Ralitza Gueorguieva, Lawrence H. Price, C. Neill Epperson |
| Abstract |
Postpartum depression (PMD) occurs in roughly 10 % of postpartum women and negatively impacts the mother and her offspring, but there are few placebo-controlled studies of antidepressant treatment in this population. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 40% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 180 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 26 | 14% |
| Student > Bachelor | 25 | 14% |
| Researcher | 19 | 10% |
| Other | 15 | 8% |
| Student > Ph. D. Student | 14 | 8% |
| Other | 31 | 17% |
| Unknown | 52 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 25% |
| Psychology | 26 | 14% |
| Nursing and Health Professions | 15 | 8% |
| Agricultural and Biological Sciences | 14 | 8% |
| Neuroscience | 11 | 6% |
| Other | 18 | 10% |
| Unknown | 53 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2022.
All research outputs
#1,958,420
of 24,876,519 outputs
Outputs from Psychopharmacology
#469
of 5,578 outputs
Outputs of similar age
#17,862
of 219,631 outputs
Outputs of similar age from Psychopharmacology
#6
of 53 outputs
Altmetric has tracked 24,876,519 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,578 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 219,631 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.